June 2026
1. CHENG Y, Qian Z, Wang R, Liang Y, et al
   Predictive value of the Hemoglobin, Albumin, Lymphocyte, and Platelet score for mortality in asthma.
   Ann Allergy Asthma Immunol. 2026 Jun 3:S1081-1206(26)00259.
   

   >> Share

   
   
2. DAULAT S
   Small airways dysfunction in asthma: Role of diet?
   Ann Allergy Asthma Immunol. 2026;136:718.
   

   >> Share

   
   May 2026
3. BOUGHER C, Raval D, Thomas S, Abuqubo R, et al
   Co-occurrence of Bronchiectasis Among Chronic Rhinosinusitis Patients Based on Associated Asthma.
   Ann Allergy Asthma Immunol. 2026 May 31:S1081-1206(26)00233.
   

   >> Share

   
   
4. GRONNIER M, Ramakrishnan S, Beasley RW, Pavord ID, et al
   After the escalator: narrative review of biomarker-guided asthma care.
   Ann Allergy Asthma Immunol. 2026 May 27:S1081-1206(26)00231.
   

   >> Share

   
   
5. BUSSE WW, Castro M, Lugogo NL, O'Byrne PM, et al
   Improved asthma outcomes for dupilumab plus medium-dose inhaled corticosteroids versus placebo plus high-dose inhaled corticosteroids.
   Ann Allergy Asthma Immunol. 2026 May 23:S1081-1206(26)00223.
   

   >> Share

   
   
6. BOURDIN A, Pavord ID, Ballew N, Butcher B, et al
   Depemokimab reduces asthma exacerbations similarly to other biologics: systematic trial review and indirect treatment comparison.
   Ann Allergy Asthma Immunol. 2026 May 21:S1081-1206(26)00218.
   

   >> Share

   
   
7. LANZ MJ, Cespedes LH, Chartrand EM, Eisenlohr CP, et al
   Utility of Exhaled Nitric Oxide as a Potential Biomarker in Non-Asthmatics with Multiple Food Allergies.
   Ann Allergy Asthma Immunol. 2026 May 11:S1081-1206(26)00196.
   

   >> Share

   
   
8. OPPENHEIMER JJ
   What's new in the care of patients with asthma?
   Ann Allergy Asthma Immunol. 2026;136:501.
   

   >> Share

   
   
9. SUTER P, Greig R, Lipworth BJ
   Bucher indirect treatment comparison of phase 3 trials with dupilumab and tezepelumab in chronic rhinosinusitis with nasal polyps.
   Ann Allergy Asthma Immunol. 2026;136:589-595.
   

   >> Share

   
   
10. LIPWORTH B, Zambelli E, Agazzi R, Piraino A, et al
    Relative particle size and distribution of inhaled triple therapies.
    Ann Allergy Asthma Immunol. 2026;136:545-549.
    

    >> Share

    
    April 2026
11. COUILLARD S, Petousi N, Ramakrishnan S, Valle R, et al
    Protocol for a multinational, investigator-initiated, parallel group, randomised, double-blind, placebo-controlled phase 3b superiority trial assessing the effect of dupilumab on inducing clinical remission outcomes in at-risk type-2 inflammatory asth
    Ann Allergy Asthma Immunol. 2026 Apr 10:S1081-1206(26)00150.
    

    >> Share

    
    
12. ABD AE, Trottier H, Tse SM, Masse B, et al
    Impact of vitamin D status and supplementation on exploratory inflammatory biomarkers in preschoolers with asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 9:S1081-1206(26)00128.
    

    >> Share

    
    
13. HAKANSSON KEJ, Hansen S, Soendergaard MB, Sverrild A, et al
    Five-year inhaled, systemic and total corticosteroid exposure reduction during anti-Interleukin-5/Ralpha treatment for severe asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 3:S1081-1206(26)00148.
    

    >> Share

    
    
14. LUGOGO NL, Silver J, Busse WW, Laliberte F, et al
    Mepolizumab Demonstrates Quantifiable Reduction in Corticosteroid-Related Adverse Effects in Severe Asthma.
    Ann Allergy Asthma Immunol. 2026 Apr 3:S1081-1206(26)00146.
    

    >> Share

    
    
15. ORANGE JS, Chinen J, Horner CC, Kobrynski LJ, et al
    2025 Inborn errors of immunity practice parameter: Guidance from the Joint Task Force on Practice Parameters, the American Academy of Allergy, Asthma & Immunology (AAAAI), the American College of Allergy, Asthma and Immunology (ACAAI) and the Clinical
    Ann Allergy Asthma Immunol. 2026;136:426-493.
    

    >> Share

    
    March 2026
16. MARQUES-MEJIAS A, Bartha I, Ciaccio CE, Chinthrajah RS, et al
    Corrigendum to 'Skin as the target for allergy prevention and treatment' [Annals of Allergy, Asthma & Immunology, Volume 133, Issue 2 (2024) 133-143].
    Ann Allergy Asthma Immunol. 2026 Mar 28:S1081-1206(26)00116.
    

    >> Share

    
    
17. XIAO Z, Zhang H, Peng Y, Zheng R, et al
    A single-cell atlas of the human airways from patients with allergic rhinitis comorbid with asthma.
    Ann Allergy Asthma Immunol. 2026 Mar 24:S1081-1206(26)00119.
    

    >> Share

    
    
18. MCCANN WA, Chipps BE, Beuther DA, Zeiger RS, et al
    Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities.
    Ann Allergy Asthma Immunol. 2026 Mar 22:S1081-1206(26)00120.
    

    >> Share

    
    
19. HAN YY, Yue M, Pereira K, Rosser FJ, et al
    Persistent exposure to second-hand smoke and asthma endotypes in a study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2026 Mar 22:S1081-1206(26)00118.
    

    >> Share

    
    
20. GREIMANN E, Lin CH, Freigeh G, Nelson B, et al
    Treatment for Mild Asthma: What Matters to Providers.
    Ann Allergy Asthma Immunol. 2026 Mar 10:S1081-1206(26)00096.
    

    >> Share

    
    
21. ADGENT MA, Gebretsadik T, Moore PE, Hartman TJ, et al
    Gestational diabetes and childhood lung function at age 8 to 9 years in a diverse US cohort.
    Ann Allergy Asthma Immunol. 2026;136:282-287.
    

    >> Share

    
    February 2026
22. CHEN R, Talapatra K, Ali S, Lyu J, et al
    Effect of background asthma and allergic conditions on prophylaxis and treatment of COVID-19 infection.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00070.
    

    >> Share

    
    
23. COYLE L, McDowell PJ, Heaney LG
    Lessons learned regarding optimal use of biologics to achieve disease remission in severe asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00069.
    

    >> Share

    
    
24. KHARBANDA S, Stocker L, Rupani H
    Asthma in pregnancy: optimising treatment strategies and the emerging role of biologic therapies.
    Ann Allergy Asthma Immunol. 2026 Feb 28:S1081-1206(26)00071.
    

    >> Share

    
    
25. BOZEK A, Urbaniec E, Miodonska M, Scierski W, et al
    Efficacy of Omalizumab in Moderate Chronic Rhinosinusitis With Nasal Polyps and Immunoglobulin E-Mediated Asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 27:S1081-1206(26)00073.
    

    >> Share

    
    
26. ERKMAN JL, Nowak-Wegrzyn A, Joseph S, Kesebir D, et al
    Aerodigestive eosinophils in children with severe uncontrolled asthma.
    Ann Allergy Asthma Immunol. 2026 Feb 14:S1081-1206(26)00058.
    

    >> Share

    
    
27. LUGOGO NL, Han JK, Peters AT, Lee SE, et al
    Tezepelumab's effects on patient-reported symptoms in severe asthma, overall and with history of comorbid CRSwNP.
    Ann Allergy Asthma Immunol. 2026 Feb 13:S1081-1206(26)00057.
    

    >> Share

    
    
28. GUPTA MR, Bingemann TA
    Who actually has asthma? The challenge of defining and diagnosing asthma.
    Ann Allergy Asthma Immunol. 2026;136:125-126.
    

    >> Share

    
    January 2026
29. ROBILLARD K, Crooks JL, Leung D, Hui-Beckman JW, et al
    LABA Use in Asthmatics is Not Associated with an Increased Severity of OFC Reactions.
    Ann Allergy Asthma Immunol. 2026 Jan 18:S1081-1206(26)00023.
    

    >> Share

    
    
30. SUZUKAWA M, Ohta K, Hashimoto H, Oyamada Y, et al
    Corrigendum to 'Characterization and cluster analyses of elderly asthma in comparison with non-elderly asthma patients in Japan' [Annals of Allergy, Asthma & Immunology, Volume 130, Issue 5 (2023) 607-616.e3].
    Ann Allergy Asthma Immunol. 2026 Jan 14:S1081-1206(25)01382.
    

    >> Share

    
    
31. HANNA ME, Ledford DK
    As-needed plus maintenance inhaled corticosteroid for asthma management: A safe, not excessive treatment strategy.
    Ann Allergy Asthma Immunol. 2026;136:3-4.
    

    >> Share

    
    
32. TUNCERLER G, Bese SA, Sahin C, Torer N, et al
    Fresh clothes, hard breaths: Laundry washing habits, detergents, softeners, and impaired respiratory functions in children with wheezing.
    Ann Allergy Asthma Immunol. 2026;136:85-91.
    

    >> Share

    
    December 2025
33. SHER ER, Golant A, de Bruin-Weller M, Carrascosa JM, et al
    Lebrikizumab is Efficacious in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Regardless of Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Dec 21:S1081-1206(25)01389.
    

    >> Share

    
    
34. HUSSEY V, Cottini M, Chan R, Galant SP, et al
    Beyond the asthma guidelines: look under the hood, particularly in those considered well controlled.
    Ann Allergy Asthma Immunol. 2025 Dec 11:S1081-1206(25)01380.
    

    >> Share

    
    
35. WATKINSON RL, Montgomery ST, Berry L, Gwatimba A, et al
    A differentiated nasal epithelial cell model derived from children with acute wheeze and asthma.
    Ann Allergy Asthma Immunol. 2025 Dec 10:S1081-1206(25)01378.
    

    >> Share

    
    
36. LEE Y, Chang JH, Kim C, Lee E, et al
    Clustering of patients with severe asthma based on long-term FEV1% changes: Real-world evidence.
    Ann Allergy Asthma Immunol. 2025 Dec 5:S1081-1206(25)01371.
    

    >> Share

    
    
37. HUSSIEN H, Moore DL, Nimri S, Bilaver LA, et al
    The Age of Eczema Onset and Multiple Food Allergies.
    Ann Allergy Asthma Immunol. 2025 Dec 3:S1081-1206(25)01369.
    

    >> Share

    
    
38. GRAYSON MH
    2025 American College of Allergy, Asthma and Immunology Annals fellow-in-training award winners: The future of allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;135:614-615.
    

    >> Share

    
    November 2025
39. CRAWFORD W, Puttock EJ, Zeiger RS, Schatz M, et al
    Statins Associate with Reduced Asthma Exacerbation Risk In Black and Obese Patients with Mild Asthma.
    Ann Allergy Asthma Immunol. 2025 Nov 28:S1081-1206(25)01365.
    

    >> Share

    
    
40. SUZAKI I, Tanaka A, Teguchi S, Teguchi Y, et al
    Dupilumab achieves clinical remission of comorbid asthma in patients with high-burden eosinophilic chronic rhinosinusitis.
    Ann Allergy Asthma Immunol. 2025 Nov 21:S1081-1206(25)01357.
    

    >> Share

    
    October 2025
41. SALAS PS, Villareal DT, Tejwani V, Koirala A, et al
    Hyperglycemia, receptor for advanced glycation end products, and small airways dysfunction in asthma.
    Ann Allergy Asthma Immunol. 2025 Oct 24:S1081-1206(25)01290.
    

    >> Share

    
    
42. FELESZKO W, Caminati M, Gern JE, Johnston SL, et al
    Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
    Ann Allergy Asthma Immunol. 2025 Oct 8:S1081-1206(25)01201.
    

    >> Share

    
    
43. ARIUE B, Patel NC, Bellanti JA
    Lessons from the ACAAI IEI Survey: Advancing Diagnostic and Therapeutic Strategies for the Practicing Allergist-Immunologist.
    Ann Allergy Asthma Immunol. 2025 Oct 5:S1081-1206(25)01224.
    

    >> Share

    
    September 2025
44. KUNG TJ, Weng CF, Wu SC, Lin FJ, et al
    Comparative Effectiveness of Fixed-Dose ICS/LABA Therapy in Adult Patients with Asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 29:S1081-1206(25)01205.
    

    >> Share

    
    
45. THOMPSON D, Visness CM, Wood RA, O'Connor GT, et al
    Associations between body weight, asthma burden, and T2 inflammation among under-resourced children.
    Ann Allergy Asthma Immunol. 2025 Sep 27:S1081-1206(25)01204.
    

    >> Share

    
    
46. AMADO C, Lopez-Padilla D, Mendez R, Martinez-Garcia MA, et al
    AIRWAY OVERLAP SYNDROMES WITH ASTHMA.
    Ann Allergy Asthma Immunol. 2025 Sep 18:S1081-1206(25)01168.
    

    >> Share

    
    
47. TIOTIU A, Pilette C, Bagnasco D, Bondi B, et al
    Comparative analysis of biologics' effects on lung function parameters in severe asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
    

    >> Share

    
    
48. JHANG YS, Chang HC, Gau SY
    Risk of asthma in US adults with COVID-19 in real-world settings.
    Ann Allergy Asthma Immunol. 2025;135:347-348.
    

    >> Share

    
    
49. ABDELKADER S, Voladri DR, Kennedy JL
    Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
    Ann Allergy Asthma Immunol. 2025;135:249-260.
    

    >> Share

    
    August 2025
50. PATERSON F, On JY, Ahmed D, Poto R, et al
    Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
    Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
    

    >> Share

    
    
51. GHABOUSIAN A, Bezerra GN, Zhu Z, Espinola JA, et al
    Impact of varying childhood asthma definitions on incidence and clinical outcomes.
    Ann Allergy Asthma Immunol. 2025 Aug 14:S1081-1206(25)00414.
    

    >> Share

    
    
52. KHEZRIAN M, Kerkhof M, Le TT, Harrison T, et al
    Adherence to inhaled corticosteroid medications following an asthma exacerbation and the risk of subsequent exacerbations.
    Ann Allergy Asthma Immunol. 2025 Aug 13:S1081-1206(25)00416.
    

    >> Share

    
    July 2025
53. GALLETTA F, Passanisi S, Randazzese SF, Licari A, et al
    Real-Life Evaluation of Biologics in Pediatric Severe Asthma Using Core Outcome Measures for Severe Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 31:S1081-1206(25)00395.
    

    >> Share

    
    
54. GREIG R, Chan R, Lipworth B
    Type 2 biomarkers and airway hyper-responsiveness disconnect in uncontrolled severe asthma patients taking benralizumab or dupilumab.
    Ann Allergy Asthma Immunol. 2025 Jul 26:S1081-1206(25)00379.
    

    >> Share

    
    
55. CORONEL AC, Sanchez-Tamay NM, Ballena-Caicedo J, Zuzunaga-Montoya FE, et al
    Prevalence of asthma in adults in Latin America: a systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00375.
    

    >> Share

    
    
56. ONGTENGCO A, Wilt E, Hardy P, Youssef C, et al
    "Getting in and doing it personally": Engagement Strategies for Rural School Asthma Programs.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
    

    >> Share

    
    
57. MENDOZA LE, Casilang CG, Morphew T, Barrows J, et al
    Feasibility of Remote Patient Monitoring to Increase Inhaled Corticosteroid Adherence in Children with High-Risk Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 23:S1081-1206(25)00369.
    

    >> Share

    
    
58. KAZANCIOGLU A, Ozdemiral C, Cetinkaya PG, Ocak M, et al
    Long-term risk of allergic diseases following allergic proctocolitis: A clinical perspective.
    Ann Allergy Asthma Immunol. 2025 Jul 21:S1081-1206(25)00371.
    

    >> Share

    
    
59. CHIPPS BE, Panettieri RA Jr, Skolnik N, Cappelletti C, et al
    Albuterol-budesonide rescue inhaler for asthma: patterns of use and safety in the MANDALA trial.
    Ann Allergy Asthma Immunol. 2025 Jul 13:S1081-1206(25)00348.
    

    >> Share

    
    
60. BUSSE WW
    Oh Eosinophil, what can you tell us about asthma?
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00347.
    

    >> Share

    
    
61. COTE A, Beach J, Reynolds J, Usuba K, et al
    ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): oral corticosteroid and short-acting beta(2)-agonist overuse.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00346.
    

    >> Share

    
    
62. MAHMOOD LZ, Perry TT, Jefferson AA, Berlinski A, et al
    Implications of removing race from spirometry reference equations in children with asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00343.
    

    >> Share

    
    
63. MISRA G, Grohman R, Kazachkov M, Nowak-Wegrzyn A, et al
    Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame?
    Ann Allergy Asthma Immunol. 2025 Jul 2:S1081-1206(25)00338.
    

    >> Share

    
    
64. JUBRAN J, Tam JS
    Identifying patients with uncontrolled asthma or severe asthma: Does terminology matter?
    Ann Allergy Asthma Immunol. 2025;135:13-14.
    

    >> Share

    
    
65. NGO SY, Anderson WC 3rd
    Weighing real-world studies when choosing a biologic for asthma: Insights and pitfalls.
    Ann Allergy Asthma Immunol. 2025;135:11-12.
    

    >> Share

    
    June 2025
66. YE Z, Harrar SW, Beyene J, Mersha TB, et al
    Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification.
    Ann Allergy Asthma Immunol. 2025 Jun 26:S1081-1206(25)00321.
    

    >> Share

    
    
67. OMAR W, Hardy P, Pappalardo AA
    National Asthma Control Program: Funding Simple, Effective Strategies to Reduce Asthma Burden and Costs.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00319.
    

    >> Share

    
    
68. PALLER AS, Soong W, Boguniewicz M, Geng B, et al
    Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00315.
    

    >> Share

    
    
69. AYACHE M, Khalid F
    Increased Likelihood of COVID-19-Related Asthma Exacerbation with Higher Eosinophil Count.
    Ann Allergy Asthma Immunol. 2025 Jun 21:S1081-1206(25)00316.
    

    >> Share

    
    
70. HAMADA Y, Thomas D, McDonald VM, Harvey ES, et al
    Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2025 Jun 20:S1081-1206(25)00309.
    

    >> Share

    
    
71. RAYNER DG, Bakaa L, Hoyte F, Perry TT, et al
    Triple therapy versus dual inhaler therapy for moderate-to-severe asthma: an updated systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jun 12:S1081-1206(25)00287.
    

    >> Share

    
    
72. HENAO MP, Malerich J, George DR
    Impact of Language Barriers on Pulmonary Function and Asthma Control.
    Ann Allergy Asthma Immunol. 2025 Jun 8:S1081-1206(25)00278.
    

    >> Share

    
    
73. WU Y, Xu W
    Refining asthma disparity research: A call for multidimensional assessment of Aspergillus fumigatus sensitization.
    Ann Allergy Asthma Immunol. 2025;134:739-740.
    

    >> Share

    
    
74. SALMON MK, Arya P, Backer V, Aanaes K, et al
    Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States.
    Ann Allergy Asthma Immunol. 2025;134:671-675.
    

    >> Share

    
    
75. HAN JK, Silver J, Dhangar I, Veeranki P, et al
    Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps: A retrospective US database study.
    Ann Allergy Asthma Immunol. 2025;134:685-693.
    

    >> Share

    
    May 2025
76. HAZLITT R, Nguyen K, Wilson A, Clark P, et al
    Diversity, Equity, and Inclusion in Asthma Clinical Trials: A Cross-Sectional Analysis.
    Ann Allergy Asthma Immunol. 2025 May 27:S1081-1206(25)00267.
    

    >> Share

    
    
77. MA R, Zhang C, Zhang Y, Tan H, et al
    The Impact of Respiratory Syncytial Virus on Asthma Development and Exacerbation.
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00236.
    

    >> Share

    
    
78. PUPPELS GJ, Hourihane JO, Nico C, Chaoimh CN, et al
    Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464].
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00220.
    

    >> Share

    
    
79. KIM Y, Moonie S, Kim I, Yoo JW, et al
    Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
    Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
    

    >> Share

    
    
80. NARLA S, Silverberg JI
    Current updates in the epidemiology and comorbidities of atopic dermatitis.
    Ann Allergy Asthma Immunol. 2025 May 9:S1081-1206(25)00228.
    

    >> Share

    
    
81. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
    Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
    Ann Allergy Asthma Immunol. 2025;134:535-538.
    

    >> Share

    
    
82. MURAI Y, Koya T, Koda H, Uji W, et al
    Dupilumab efficacy in relation to changes in club cell secretory protein 16.
    Ann Allergy Asthma Immunol. 2025;134:556-562.
    

    >> Share

    
    April 2025
83. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
    The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
    Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
    

    >> Share

    
    
84. SCOTT EA, Balasubramanian A, Brems JH, Wu TD, et al
    Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings.
    Ann Allergy Asthma Immunol. 2025 Apr 18:S1081-1206(25)00183.
    

    >> Share

    
    
85. SCURLOCK AM, Fleischer DM, Toit GD, Arends NJT, et al
    Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-allergic Children with Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Apr 7:S1081-1206(25)00179.
    

    >> Share

    
    
86. GARDNER DD, Gokani R, Hey-Hadavi J, Williams D, et al
    Healthcare-Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey.
    Ann Allergy Asthma Immunol. 2025 Apr 3:S1081-1206(25)00175.
    

    >> Share

    
    
87. GRAYSON MH
    Asthma and evolving trends in allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;134:369.
    

    >> Share

    
    March 2025
88. KALRA S, Kalra D, Nagaraja N, Hlaing WM, et al
    Food Allergy and Asthma in a Nationally Representative Sample of Adolescents in the United States.
    Ann Allergy Asthma Immunol. 2025 Mar 28:S1081-1206(25)00152.
    

    >> Share

    
    
89. TO M, Arimoto Y, Honda N, Furusho N, et al
    Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00126.
    

    >> Share

    
    
90. FAN H, Ren Z, Zhang P, Zhou B, et al
    Increased asthma burden during and post the COVID-19 pandemic among U.S. adults.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123.
    

    >> Share

    
    
91. VIINANEN A, Ilmarinen P, Mehtala J, Jylhava J, et al
    Factors associated with the development of severe asthma - a nationwide study (FINASTHMA).
    Ann Allergy Asthma Immunol. 2025 Mar 9:S1081-1206(25)00119.
    

    >> Share

    
    
92. GELB AF, Tashkin DP
    Utility of using thoracic computed tomography to measure lung function decline and detect unsuspected emphysema in severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:253-254.
    

    >> Share

    
    
93. TANABE N
    Further evidence for the roles of computed tomography in managing severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:251-252.
    

    >> Share

    
    
94. MATHUR SK, Silver J, MacKnight SD, Urosevic A, et al
    Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
    Ann Allergy Asthma Immunol. 2025;134:341-350.
    

    >> Share

    
    February 2025
95. LUGOGO NL, Gilbert IA, Gandhi HN, Tkacz JP, et al
    Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting beta(2)-agonist rescue.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00088.
    

    >> Share

    
    
96. SKEEN E, Hamlington KL, De Keyser H, Liu AH, et al
    Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00092.
    

    >> Share

    
    
97. CEGOLON L, Filon FL, Lange JH
    Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:125-126.
    

    >> Share

    
    
98. GALANT SP
    Oscillometry-determined small airway dysfunction as a significant risk for poor asthma control and exacerbations.
    Ann Allergy Asthma Immunol. 2025;134:123-124.
    

    >> Share

    
    January 2025
99. BRUZZESE JM, Cespedes A, Ainapudi V, Kingston S, et al
    Barriers to Seeing a Healthcare Provider among Rural Adolescents with Poorly Controlled Asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00046.
    

    >> Share

    
    
100. GREIG R, Chan R, Fardon TC, Lipworth BJ, et al
     Real world effects of tezepelumab on small airways dysfunction in severe refectory asthma.
     Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00064.
     

     >> Share

     
     
101. COTTINI M, Ventura L, Lombardi C, Landi M, et al
     Small airway dysfunction mediates the relationship between FeNO and asthma control.
     Ann Allergy Asthma Immunol. 2025 Jan 16:S1081-1206(25)00004.
     

     >> Share

     
     
102. LEE JK, Pollard SJ, Liu MC, Schleich F, et al
     Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
     Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003.
     

     >> Share

     
     
103. OPPENHEIMER J, Casale T
     Care of asthma-a rapidly moving story.
     Ann Allergy Asthma Immunol. 2025;134:1-2.
     

     >> Share

     
     December 2024
104. MILIGKOS M, Oh J, Kwon R, Konstantinou GNu, et al
     Epidemiology of asthma across the ages.
     Ann Allergy Asthma Immunol. 2024 Dec 12:S1081-1206(24)01727.
     

     >> Share

     
     
105. ELLIOTT MR, O'Connor AE, Marshall GD
     Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
     Ann Allergy Asthma Immunol. 2024 Dec 7:S1081-1206(24)01716.
     

     >> Share

     
     
106. OU MC, Tsai RY, Li CP, Gau SY, et al
     Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024;133:732-733.
     

     >> Share

     
     
107. CHAN R, Kuo CR, Fardon T, Thouseef MJ, et al
     The interplay between skeletal muscle adiposity and radiographic features of airway remodeling in persistent asthma.
     Ann Allergy Asthma Immunol. 2024;133:626-627.
     

     >> Share

     
     November 2024
108. ZHANG B, Yan M, Li C, Zhao J, et al
     Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01712.
     

     >> Share

     
     
109. LANZ MJ, Chipps B, Zeiger RS, Bacharier LB, et al
     Pediatric Asthma Impairment and Risk Questionnaire: Rationale and Development of a Composite Control Tool.
     Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01711.
     

     >> Share

     
     
110. CONWAY AE, Marshall GD, Oppenheimer J, Shaker MS, et al
     Should Biologics Be Available for All Patients with Uncontrolled Asthma, Regardless? Absolutely and Here's Why.
     Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01713.
     

     >> Share

     
     
111. GREIMANN E, Freigeh GE, Wettenstein RP, Nelson B, et al
     Mild Asthma- What Matters to Patients and Parents.
     Ann Allergy Asthma Immunol. 2024 Nov 26:S1081-1206(24)01708.
     

     >> Share

     
     
112. DUCHARME FM, Chan R
     Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults: review article.
     Ann Allergy Asthma Immunol. 2024 Nov 25:S1081-1206(24)01702.
     

     >> Share

     
     
113. GOCHICOA-RANGEL L, Vargas MH
     How best to choose an oscillometer and reference equations for your patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 16:S1081-1206(24)01681.
     

     >> Share

     
     
114. COTTINI M, Lombardi C, Comberiati P, Berti A, et al
     Oscillometry-defined small airways dysfunction as a treatable trait in asthma.
     Ann Allergy Asthma Immunol. 2024 Nov 15:S1081-1206(24)01658.
     

     >> Share

     
     
115. ZHANG W, Li L, Zhang Y, Dai J, et al
     Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
     Ann Allergy Asthma Immunol. 2024 Nov 14:S1081-1206(24)01657.
     

     >> Share

     
     
116. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
     Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunolo
     Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630.
     

     >> Share

     
     
117. YU JT, Gau SY, Li CP, Chang HC, et al
     Real-world association between cat ownership and asthma.
     Ann Allergy Asthma Immunol. 2024;133:613.
     

     >> Share

     
     
118. SHEN CY, Li CP, Tsai RY, Chang HC, et al
     Infant urinary adrenal steroids and childhood asthma development.
     Ann Allergy Asthma Immunol. 2024;133:611-612.
     

     >> Share

     
     
119. GRAYSON MH
     The future of allergy and immunology research: 2024 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
     Ann Allergy Asthma Immunol. 2024;133:505-506.
     

     >> Share

     
     
120. ESCHENBACHER WH
     Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma.
     Ann Allergy Asthma Immunol. 2024;133:497-498.
     

     >> Share

     
     October 2024
121. RAO R, Han YY, Valentin-Rodriguez LA, Presto AA, et al
     Proximity to Fast-Food Restaurants and Pediatric Asthma Outcomes.
     Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01631.
     

     >> Share

     
     
122. RUPPRECHT C, Krishnaswamy G
     OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS.
     Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01632.
     

     >> Share

     
     
123. GALLEGOS-KOYNER FJ, Hodo F, Barrera NI, Cerrud-Rodriguez RC, et al
     Opioid Use Disorder's Impact on Asthma Hospitalizations: A Propensity Matched Nationwide Study.
     Ann Allergy Asthma Immunol. 2024 Oct 18:S1081-1206(24)01577.
     

     >> Share

     
     
124. MANKA LA, Guntur VP, Stevens AD, Kolakowski C, et al
     The Supraglottic Index: An Indicator of Response to Laryngopharyngeal Reflux Therapy in Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 15:S1081-1206(24)01573.
     

     >> Share

     
     
125. ZIDAN E, Wilson G, Shin JJ, Chupp G, et al
     The Next Frontier: Defining and Optimizing Treatments for Patients with T2 Low Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 14:S1081-1206(24)01571.
     

     >> Share

     
     
126. SELUK L, Davis AE, Rhoads S, Wechsler ME, et al
     Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 9:S1081-1206(24)01552.
     

     >> Share

     
     
127. MAILHOT-LAROUCHE S, Celis-Preciado C, Heaney LG, Couillard S, et al
     Identifying Super-Responders: a Review of the Road to Asthma Remission.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01559.
     

     >> Share

     
     
128. GREIG R, Stewart K, Chan R, Lipworth B, et al
     Assessment of bronchodilator responsiveness using low frequency impedance in type 2 high uncontrolled severe asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01570.
     

     >> Share

     
     
129. BUSSE WW
     The Role of Biologics in Inducing Remission in Asthma.
     Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01557.
     

     >> Share

     
     
130. MIYATA Y, Tanaka A, Ebato T, Kashima A, et al
     Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
     Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553.
     

     >> Share

     
     
131. WEINBERGER MM, Hendeles L
     Biologics for asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024;133:356-357.
     

     >> Share

     
     
132. CORELLI ER, Peebles RS Jr
     Race toward more equitable pulmonary function testing?
     Ann Allergy Asthma Immunol. 2024;133:362-363.
     

     >> Share

     
     
133. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
     Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
     Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
     

     >> Share

     
     September 2024
134. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
     Metabolic and weight components' impact on incident asthma using a real-world cohort.
     Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
     

     >> Share

     
     
135. CHAN R, Lipworth B
     Airway oscillometry in asthma - present and future perspectives.
     Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
     

     >> Share

     
     
136. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
     Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
     Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
     

     >> Share

     
     
137. SIM DW, Choi S, Jeong J, Lee SY, et al
     Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
     Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
     

     >> Share

     
     
138. KAIDASHEV I, Ditiatkovskaya E
     Managing Asthma and Allergies during the Russo-Ukrainian War.
     Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
     

     >> Share

     
     
139. SHAMIM J
     The relationship of height and asthma.
     Ann Allergy Asthma Immunol. 2024;133:352.
     

     >> Share

     
     
140. PHILIPENKO BS, Davis B, Cockcroft DW
     To stop or not to stop an asthma biologic, that is the question.
     Ann Allergy Asthma Immunol. 2024;133:236-237.
     

     >> Share

     
     
141. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
     Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
     Ann Allergy Asthma Immunol. 2024;133:310-317.
     

     >> Share

     
     August 2024
142. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
     Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
     Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
     

     >> Share

     
     
143. HAGWOOD SR, Elliott M, Marshall GD
     Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
     Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
     

     >> Share

     
     
144. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
     Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
     

     >> Share

     
     
145. MALDONADO-PUEBLA M, Ledford D, Cardet JC
     The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024;133:123-124.
     

     >> Share

     
     
146. STEWART K, Kuo CR, Chan R, Lipworth B, et al
     Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
     Ann Allergy Asthma Immunol. 2024;133:211-213.
     

     >> Share

     
     July 2024
147. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
     Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
     

     >> Share

     
     
148. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
     Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
     

     >> Share

     
     
149. HAN YY, Celedon JC
     The Effects of Violence and Related Stress on Asthma.
     Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
     

     >> Share

     
     
150. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
     Community Violence and Asthma: A Review.
     Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
     

     >> Share

     
     
151. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
     Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
     Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
     

     >> Share

     
     
152. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
     Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
     

     >> Share

     
     
153. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
     Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
     Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
     

     >> Share

     
     
154. SIM S, Jang JH, Park HS
     Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
     Ann Allergy Asthma Immunol. 2024;133:7-8.
     

     >> Share

     
     
155. GUTIERREZ CG, Bukstein DA
     Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
     Ann Allergy Asthma Immunol. 2024;133:5-6.
     

     >> Share

     
     
156. HARRIS D, Borish L
     How we treat type 2 low asthma.
     Ann Allergy Asthma Immunol. 2024;133:43-46.
     

     >> Share

     
     
157. MULLUR J, Buchheit KM
     Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
     Ann Allergy Asthma Immunol. 2024;133:118.
     

     >> Share

     
     June 2024
158. TRASANDE L
     The Role of Plastics in Allergy, Immunology and Human Health: What the Clinician Needs to Know and Can Do About It.
     Ann Allergy Asthma Immunol. 2024 Jun 28:S1081-1206(24)00417.
     

     >> Share

     
     
159. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
     Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
     Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
     

     >> Share

     
     
160. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
     Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
     Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
     

     >> Share

     
     
161. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
     Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
     Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
     

     >> Share

     
     
162. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
     Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
     Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
     

     >> Share

     
     
163. ZEIGER JS, Silvers WS, Zeiger RS
     Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
     Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
     

     >> Share

     
     
164. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
     Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
     Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
     

     >> Share

     
     
165. SEDAGHAT AR, Phillips KM
     Unifying the airway through multiomics.
     Ann Allergy Asthma Immunol. 2024;132:667-668.
     

     >> Share

     
     May 2024
166. BELLANTI JA, Settipane RA
     Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
     Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
     

     >> Share

     
     
167. PETERSEN M, Bingemann TA
     Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
     Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
     

     >> Share

     
     
168. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
     Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
     Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
     

     >> Share

     
     
169. KLOEPFER KM, Kennedy JL
     Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
     Ann Allergy Asthma Immunol. 2024;132:553-554.
     

     >> Share

     
     
170. KATIAL RK, Hoyte FCL
     Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
     Ann Allergy Asthma Immunol. 2024;132:551-552.
     

     >> Share

     
     
171. BEIGELMAN A, Goss CW, Wang J, Srinivasan M, et al
     Azithromycin therapy in infants hospitalized for respiratory syncytial virus bronchiolitis: Airway matrix metalloproteinase-9 levels and subsequent recurrent wheeze.
     Ann Allergy Asthma Immunol. 2024;132:623-629.
     

     >> Share

     
     April 2024
172. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
     The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
     Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
     

     >> Share

     
     
173. WOO SD, Park HS, Yang EM, Ban GY, et al
     8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
     Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
     

     >> Share

     
     March 2024
174. MOTA D, Martins C, Puga N, Moreira A, et al
     Asthma and allergy screening in elite football athletes: is it worth it?
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
     

     >> Share

     
     
175. LEE PH, An M, Hwang D, Jang AS, et al
     Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
     

     >> Share

     
     
176. HUANG D, Zhang L, Liu Y, Wang J, et al
     Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
     

     >> Share

     
     
177. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
     Evidence for two clusters among non-eosinophilic asthmatics.
     Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
     

     >> Share

     
     
178. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
     Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
     Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
     

     >> Share

     
     
179. LI Y, Hong X, Chandran A, Keet CA, et al
     Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
     Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
     

     >> Share

     
     
180. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
     Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
     Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
     

     >> Share

     
     February 2024
181. CETIN GP, Yilmaz I
     What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
     Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
     

     >> Share

     
     
182. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
     Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
     Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
     

     >> Share

     
     January 2024
183. CHEN C, Song X, Murdock DJ, Marcus A, et al
     Association between allergic conditions and COVID-19 susceptibility and outcomes.
     Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
     

     >> Share

     
     November 2023
184. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
     Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
     Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
     

     >> Share

     
     
185. GEVAERT P, Mullol J, Saenz R, Ko J, et al
     Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
     Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share